The major pain point is that there is a shortage of pathologists, an increasing workload, and projecting a potential workforce crisis soon which could negatively impact patient care. Understanding these pain points Crosscope has realised that the cancer burden can be reduced if pathologists get access to advanced tools where they can diagnose cancers more efficiently and accurately.

The founders of Crosscope – Jayendra, Ketan and Puneet have built an AI-enabled digital pathology platform that has the potential to bring the entire pathology industry into the 21st century for a patient centric cancer care. Dr. Jayendra Shinde, the Chief Executive Officer of Crosscope is a healthcare technology leader with more than decade of experience in developing industry’s most advanced machine learning, computer vision, biomedical data and medical imaging technologies. Prior to joining Crosscope, Dr. Shinde was a postdoctoral research scholar at Stanford University leading research that leverages deep learning to transform the way cancers are diagnosed and treated. Crosscope was launched in 2020 based on technology developed by its co-founder and Chief Technology Officer Dr. Ketan Bacchuwar. He is a former research technologist from GE Healthcare from where he earned his PhD in medical image processing and computer vision. His vast command in medical imaging, machine learning, and artificial intelligence is significantly pivotal for Crosscope’s technology. In October of 2021, Puneet Pantane joined the company as a cofounder as Chief Business Officer. Pantane is a ex-GE Healthcare seasoned healthcare technology veteran who has successfully led the development and commercialization of transformative technologies rooted in medical imaging. He is a global digital healthcare transformation leader having more than 20+years of experience in Healthcare Digital Product and customer facing roles.

Crosscope includes a team of about 20 people led by management of Ph.Ds. distributed between 2 continents – India and North America. Continuing with its vision to enable next-generation AI-powered telepathology for medical image information extraction and precision diagnostics, the startup is working closely with more than 15 healthcare organisations in India, the U.S., Europe, Middle East and is looking forward to fulfilling its mission to treat cancer patients and save billions of lives.